Cargando…
Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS
OBJECTIVE: To explore the hypothesis that serum neurofilament light chain (sNfL) indicative of neuroaxonal damage may improve precise disease profiling with regard to cognition and neuropsychiatric symptoms, we analyzed potential associations of sNfL levels with cognitive test scores, fatigue, depre...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673283/ https://www.ncbi.nlm.nih.gov/pubmed/32972970 http://dx.doi.org/10.1212/NXI.0000000000000885 |
_version_ | 1783611290423394304 |
---|---|
author | Aktas, Orhan Renner, Alina Huss, André Filser, Melanie Baetge, Sharon Stute, Nathalie Gasis, Marcia Lepka, Klaudia Goebels, Norbert Senel, Makbule Graf, Jonas Enzinger, Christian Pinter, Daniela Antoch, Gerald Turowski, Bernd Hartung, Hans-Peter Albrecht, Philipp Otto, Markus Tumani, Hayrettin Penner, Iris-Katharina |
author_facet | Aktas, Orhan Renner, Alina Huss, André Filser, Melanie Baetge, Sharon Stute, Nathalie Gasis, Marcia Lepka, Klaudia Goebels, Norbert Senel, Makbule Graf, Jonas Enzinger, Christian Pinter, Daniela Antoch, Gerald Turowski, Bernd Hartung, Hans-Peter Albrecht, Philipp Otto, Markus Tumani, Hayrettin Penner, Iris-Katharina |
author_sort | Aktas, Orhan |
collection | PubMed |
description | OBJECTIVE: To explore the hypothesis that serum neurofilament light chain (sNfL) indicative of neuroaxonal damage may improve precise disease profiling with regard to cognition and neuropsychiatric symptoms, we analyzed potential associations of sNfL levels with cognitive test scores, fatigue, depression, and anxiety. METHODS: Patients with relapsing-remitting and secondary progressive MS (SPMS) underwent an elaborated assessment including MRI, various cognitive tests, and patient-reported outcomes. We determined sNfL levels by single molecule array (Simoa) assay. Relationships between sNfL, cognition, neuropsychiatric symptoms, and demographical data were analyzed using correlations, group comparisons, and regressions. RESULTS: In 45 clinically stable patients with MS (Expanded Disability Status Scale = 2.73 ± 1.12, disease duration = 10.03 ± 7.49 years), 40.0% were cognitively impaired. Mean sNfL levels were 16.02 ± 10.39 pg/mL, with higher levels in the SPMS subgroup (p = 0.038). sNfL levels did reliably link neither with the investigated cognitive and affective parameters nor with fatigue levels. The only relationship found in a small subgroup of patients with SPMS (n = 7) with visuospatial learning (r = −0.950, p = 0.001) and memory (r = −0.813; p = 0.026) disappeared when further controlling for age, educational level, and sex. CONCLUSIONS: In patients with stable MS at less advanced disease stages, sNfL did not convincingly relate to cognitive performance, fatigue, depression, or anxiety and thus may not serve as a surrogate biomarker for neuropsychological status in such populations. |
format | Online Article Text |
id | pubmed-7673283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-76732832020-11-19 Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS Aktas, Orhan Renner, Alina Huss, André Filser, Melanie Baetge, Sharon Stute, Nathalie Gasis, Marcia Lepka, Klaudia Goebels, Norbert Senel, Makbule Graf, Jonas Enzinger, Christian Pinter, Daniela Antoch, Gerald Turowski, Bernd Hartung, Hans-Peter Albrecht, Philipp Otto, Markus Tumani, Hayrettin Penner, Iris-Katharina Neurol Neuroimmunol Neuroinflamm Article OBJECTIVE: To explore the hypothesis that serum neurofilament light chain (sNfL) indicative of neuroaxonal damage may improve precise disease profiling with regard to cognition and neuropsychiatric symptoms, we analyzed potential associations of sNfL levels with cognitive test scores, fatigue, depression, and anxiety. METHODS: Patients with relapsing-remitting and secondary progressive MS (SPMS) underwent an elaborated assessment including MRI, various cognitive tests, and patient-reported outcomes. We determined sNfL levels by single molecule array (Simoa) assay. Relationships between sNfL, cognition, neuropsychiatric symptoms, and demographical data were analyzed using correlations, group comparisons, and regressions. RESULTS: In 45 clinically stable patients with MS (Expanded Disability Status Scale = 2.73 ± 1.12, disease duration = 10.03 ± 7.49 years), 40.0% were cognitively impaired. Mean sNfL levels were 16.02 ± 10.39 pg/mL, with higher levels in the SPMS subgroup (p = 0.038). sNfL levels did reliably link neither with the investigated cognitive and affective parameters nor with fatigue levels. The only relationship found in a small subgroup of patients with SPMS (n = 7) with visuospatial learning (r = −0.950, p = 0.001) and memory (r = −0.813; p = 0.026) disappeared when further controlling for age, educational level, and sex. CONCLUSIONS: In patients with stable MS at less advanced disease stages, sNfL did not convincingly relate to cognitive performance, fatigue, depression, or anxiety and thus may not serve as a surrogate biomarker for neuropsychological status in such populations. Lippincott Williams & Wilkins 2020-09-24 /pmc/articles/PMC7673283/ /pubmed/32972970 http://dx.doi.org/10.1212/NXI.0000000000000885 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Article Aktas, Orhan Renner, Alina Huss, André Filser, Melanie Baetge, Sharon Stute, Nathalie Gasis, Marcia Lepka, Klaudia Goebels, Norbert Senel, Makbule Graf, Jonas Enzinger, Christian Pinter, Daniela Antoch, Gerald Turowski, Bernd Hartung, Hans-Peter Albrecht, Philipp Otto, Markus Tumani, Hayrettin Penner, Iris-Katharina Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS |
title | Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS |
title_full | Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS |
title_fullStr | Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS |
title_full_unstemmed | Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS |
title_short | Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS |
title_sort | serum neurofilament light chain: no clear relation to cognition and neuropsychiatric symptoms in stable ms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673283/ https://www.ncbi.nlm.nih.gov/pubmed/32972970 http://dx.doi.org/10.1212/NXI.0000000000000885 |
work_keys_str_mv | AT aktasorhan serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT renneralina serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT hussandre serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT filsermelanie serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT baetgesharon serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT stutenathalie serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT gasismarcia serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT lepkaklaudia serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT goebelsnorbert serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT senelmakbule serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT grafjonas serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT enzingerchristian serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT pinterdaniela serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT antochgerald serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT turowskibernd serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT hartunghanspeter serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT albrechtphilipp serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT ottomarkus serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT tumanihayrettin serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems AT penneririskatharina serumneurofilamentlightchainnoclearrelationtocognitionandneuropsychiatricsymptomsinstablems |